Surface B7H3 on tumor cells has been shown to play a role in regulating an anti-tumor immune response by inhibiting the functions of immune cells, particularly NK cells and CD8+ T cells [14, 18, 54]. The gene discussed is CD8A; the disease is neoplasm.